Vaxart, Inc. (VXRT)

Vaxart Statistics

Total Valuation

Vaxart has a market cap or net worth of $140.95 million. The enterprise value is $105.31 million.

Market Cap	140.95M
Enterprise Value	105.31M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Vaxart has 227.48 million shares outstanding. The number of shares has increased by 27.02% in one year.

Current Share Class	227.48M
Shares Outstanding	227.48M
Shares Change (YoY)	+27.02%
Shares Change (QoQ)	+23.15%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	10.54%
Float	212.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.68
Forward PS	2.20
PB Ratio	2.06
P/TBV Ratio	2.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.34.

Current Ratio	0.83
Quick Ratio	0.78
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.56

Financial Efficiency

Return on equity (ROE) is -103.37% and return on invested capital (ROIC) is -47.30%.

Return on Equity (ROE)	-103.37%
Return on Assets (ROA)	-32.91%
Return on Capital (ROIC)	-47.30%
Revenue Per Employee	$153,761
Profits Per Employee	-$663,651
Employee Count	109
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

In the past 12 months, Vaxart has paid $258,000 in taxes.

Income Tax	258,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.04% in the last 52 weeks. The beta is 0.62, so Vaxart's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+1.04%
50-Day Moving Average	0.68
200-Day Moving Average	0.80
Relative Strength Index (RSI)	49.31
Average Volume (20 Days)	1,399,077

Short Selling Information

The latest short interest is 11.19 million, so 4.92% of the outstanding shares have been sold short.

Short Interest	11.19M
Short Previous Month	11.46M
Short % of Shares Out	4.92%
Short % of Float	5.27%
Short Ratio (days to cover)	11.71

Income Statement

In the last 12 months, Vaxart had revenue of $16.76 million and -$72.34 million in losses. Loss per share was -$0.40.

Revenue	16.76M
Gross Profit	-49.50M
Operating Income	-71.70M
Pretax Income	-75.38M
Net Income	-72.34M
EBITDA	-62.76M
EBIT	-71.70M
Loss Per Share	-$0.40

Balance Sheet

The company has $58.71 million in cash and $23.08 million in debt, giving a net cash position of $35.64 million or $0.16 per share.

Cash & Cash Equivalents	58.71M
Total Debt	23.08M
Net Cash	35.64M
Net Cash Per Share	$0.16
Equity (Book Value)	68.44M
Book Value Per Share	0.30
Working Capital	-13.91M

Cash Flow

In the last 12 months, operating cash flow was -$50.94 million and capital expenditures -$406,000, giving a free cash flow of -$51.35 million.

Operating Cash Flow	-50.94M
Capital Expenditures	-406,000
Free Cash Flow	-51.35M
FCF Per Share	-$0.23

Margins

Gross Margin	-295.37%
Operating Margin	-427.81%
Pretax Margin	-430.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vaxart does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.02%
Shareholder Yield	-27.02%
Earnings Yield	-51.32%
FCF Yield	-36.43%

Analyst Forecast

The average price target for Vaxart is $3.00, which is 384.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.00
Price Target Difference	384.18%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	84.12%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Vaxart has an Altman Z-Score of -4.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.4
Piotroski F-Score	4